Nadine Anna Schilling

Nadine Anna Schilling

Auto-generated profile, based on publicly available information

Nadine Anna Schilling

Institute of Organic Chemistry, University of Tübingen, Tübingen, Germany 11

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2018 in EMBO Reports
Verified
Journal Article
Closed access
PDF file
KFKatharina Fuchs
Katharina Fuchs
YGYamel Cardona Gloria
Yamel Cardona Gloria
OWOlaf‐Oliver Wolz
Olaf‐Oliver Wolz
FHFranziska Herster
Franziska Herster
LSLokesh Sharma
Lokesh Sharma
AWAlexander Weber
Alexander Weber

23 September 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ZBZsófia Agnes Bittner
Zsófia Agnes Bittner
XLXiao Liu
Xiao Liu
MTMaria Mateo Tortola
Maria Mateo Tortola
ATANA TAPIA-ABELLAN
ANA TAPIA-ABELLAN
SSSangeetha Shankar
Sangeetha Shankar
AWAlexander Weber
Alexander Weber
Activity of the NLRP3 inflammasome, a critical mediator of inflammation, is controlled by accessory proteins, posttranslational modifications, cellular localization, and oligomerization. How these factors relate is unclear. We show that a well-established drug target, Bruton’s tyrosine kinase (BTK), affects several levels of NLRP3 regulation. BTK directly interacts with NLRP3 in immune cells and phosphorylates four conserved tyrosine residues upon inflammasome activation, in vitro and in vivo. Furthermore, BTK promotes NLRP3 relocalization, oligomerization, ASC polymerization, and full inflammasome assembly, probably by charge neutralization, upon modification of a polybasic linker known to direct NLRP3 Golgi association and inflammasome nucleation. As NLRP3 tyrosine modification by BTK also positively regulates IL-1β release, we propose BTK as a multifunctional positive regulator of NLRP3 regulation and BTK phosphorylation of NLRP3 as a novel and therapeutically tractable step in the control of inflammation.

6 May 2019 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
NSNadine Anna Schilling
Nadine Anna Schilling
ABAnne Berscheid
Anne Berscheid
JSJohannes Schumacher
Johannes Schumacher
JSJulian Sigfried Saur
Julian Sigfried Saur
MKMartin Christoph Konnerth
Martin Christoph Konnerth
SGStephanie Grond
Stephanie Grond
Lugdunin, a novel thiazolidine cyclopeptide, exhibits micromolar activity against methicillin‐resistant Staphylococcus aureus (MRSA). For structure–activity relationship (SAR) studies, synthetic analogues obtained from alanine and stereo scanning as well as peptides with modified thiazolidine rings were tested for antimicrobial activity. The thiazolidine ring and the alternating d‐ and l‐amino acid backbone are essential. Notably, the non‐natural enantiomer displays equal activity, thus indicating the absence of a chiral target. The antibacterial activity strongly correlates with dissipation of the membrane potential in S. aureus. Lugdunin equalizes pH gradients in artificial membrane vesicles, thereby maintaining membrane integrity, which demonstrates that proton translocation is the mode of action (MoA). The incorporation of extra tryptophan or propargyl moieties further expands the diversity of this class of thiazolidine cyclopeptides.

6 May 2019 in Angewandte Chemie
Verified
Journal Article
Open access
PDF file
NSNadine A. Schilling
Nadine A. Schilling
ABAnne Berscheid
Anne Berscheid
JSJohannes Schumacher
Johannes Schumacher
JSJulian S. Saur
Julian S. Saur
MKMartin C. Konnerth
Martin C. Konnerth
SGStephanie Grond
Stephanie Grond
Lugdunin, ein neues Thiazolidin‐Cyclopeptid, weist gegenüber Methicillin‐resistentem Staphylococcus aureus (MRSA) antimikrobielle Wirkung im mikromolaren Bereich auf. Für die Untersuchung von Struktur‐Aktivitätsbeziehungen (SAR) wurden synthetische Alanin‐ und Stereo‐Derivate sowie Peptide mit modifiziertem Thiazolidinring auf ihre antimikrobielle Aktivität getestet. Sowohl das Thiazolidin als auch die d‐, l‐alternierende Konfiguration stellen essentielle Strukturmotive dar. Bemerkenswert ist die identische Aktivität des Enantiomers, was eine stereospezifische Wechselwirkung mit einem Zielmolekül ausschließt. Die antibakterielle Wirkung korreliert stark mit dem Einbrechen des Membranpotentials von S. aureus. Lugdunin gleicht pH‐Gradienten in künstlichen Membranvesikeln unter Erhalt der Membranintegrität aus. Der Wirkmechanismus (MoA) beruht somit auf Protonentransport. Der Einbau eines zusätzlichen Tryptophans oder einer Propargylfunktion erweitert die Diversität dieser neuen Substanzklasse der Thiazolidin‐Cyclopeptide.